×
S&P 500   3,775.73 (-0.25%)
DOW   30,707.86 (-0.22%)
QQQ   278.40 (-0.67%)
AAPL   136.63 (-0.07%)
MSFT   256.42 (-0.16%)
META   156.97 (-2.65%)
GOOGL   2,143.61 (-1.64%)
AMZN   107.65 (+1.36%)
TSLA   669.28 (-0.61%)
NVDA   145.01 (-4.34%)
NIO   20.99 (-3.36%)
BABA   115.03 (+1.19%)
AMD   73.28 (-4.17%)
MU   52.26 (-5.46%)
CGC   2.86 (+0.35%)
T   21.04 (+0.38%)
GE   62.84 (-1.30%)
F   11.15 (+0.18%)
DIS   94.80 (+0.42%)
AMC   13.42 (-0.96%)
PFE   51.46 (-1.85%)
PYPL   70.03 (+0.27%)
NFLX   176.64 (+1.01%)
S&P 500   3,775.73 (-0.25%)
DOW   30,707.86 (-0.22%)
QQQ   278.40 (-0.67%)
AAPL   136.63 (-0.07%)
MSFT   256.42 (-0.16%)
META   156.97 (-2.65%)
GOOGL   2,143.61 (-1.64%)
AMZN   107.65 (+1.36%)
TSLA   669.28 (-0.61%)
NVDA   145.01 (-4.34%)
NIO   20.99 (-3.36%)
BABA   115.03 (+1.19%)
AMD   73.28 (-4.17%)
MU   52.26 (-5.46%)
CGC   2.86 (+0.35%)
T   21.04 (+0.38%)
GE   62.84 (-1.30%)
F   11.15 (+0.18%)
DIS   94.80 (+0.42%)
AMC   13.42 (-0.96%)
PFE   51.46 (-1.85%)
PYPL   70.03 (+0.27%)
NFLX   176.64 (+1.01%)
S&P 500   3,775.73 (-0.25%)
DOW   30,707.86 (-0.22%)
QQQ   278.40 (-0.67%)
AAPL   136.63 (-0.07%)
MSFT   256.42 (-0.16%)
META   156.97 (-2.65%)
GOOGL   2,143.61 (-1.64%)
AMZN   107.65 (+1.36%)
TSLA   669.28 (-0.61%)
NVDA   145.01 (-4.34%)
NIO   20.99 (-3.36%)
BABA   115.03 (+1.19%)
AMD   73.28 (-4.17%)
MU   52.26 (-5.46%)
CGC   2.86 (+0.35%)
T   21.04 (+0.38%)
GE   62.84 (-1.30%)
F   11.15 (+0.18%)
DIS   94.80 (+0.42%)
AMC   13.42 (-0.96%)
PFE   51.46 (-1.85%)
PYPL   70.03 (+0.27%)
NFLX   176.64 (+1.01%)
S&P 500   3,775.73 (-0.25%)
DOW   30,707.86 (-0.22%)
QQQ   278.40 (-0.67%)
AAPL   136.63 (-0.07%)
MSFT   256.42 (-0.16%)
META   156.97 (-2.65%)
GOOGL   2,143.61 (-1.64%)
AMZN   107.65 (+1.36%)
TSLA   669.28 (-0.61%)
NVDA   145.01 (-4.34%)
NIO   20.99 (-3.36%)
BABA   115.03 (+1.19%)
AMD   73.28 (-4.17%)
MU   52.26 (-5.46%)
CGC   2.86 (+0.35%)
T   21.04 (+0.38%)
GE   62.84 (-1.30%)
F   11.15 (+0.18%)
DIS   94.80 (+0.42%)
AMC   13.42 (-0.96%)
PFE   51.46 (-1.85%)
PYPL   70.03 (+0.27%)
NFLX   176.64 (+1.01%)

UnitedHealth Group Price Target, Predictions & Analyst Ratings

$507.01
-6.62 (-1.29%)
(As of 07/1/2022 12:51 PM ET)
Add
Compare
Today's Range
$502.40
$512.32
50-Day Range
$452.06
$524.42
52-Week Range
$383.12
$553.29
Volume
54,562 shs
Average Volume
3.45 million shs
Market Capitalization
$475.66 billion
P/E Ratio
27.75
Dividend Yield
1.28%
Price Target
$560.76

UnitedHealth Group (NYSE:UNH) Price Target and Consensus Rating (2022)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Analyst Rating

Moderate Buy
Based on 22 Analyst Ratings

Consensus Analyst Price Target

$560.76
10.60% Upside
High Price Target$620.00
Average Price Target$560.76
Low Price Target$452.00
TypeCurrent
7/1/21 to 7/1/22
1 Month Ago
6/1/21 to 6/1/22
3 Months Ago
4/2/21 to 4/2/22
1 Year Ago
7/1/20 to 7/1/21
Consensus Rating
Moderate Buy
Moderate Buy
Moderate Buy
Moderate Buy
Strong Buy
1 Strong Buy rating(s)
1 Strong Buy rating(s)
1 Strong Buy rating(s)
1 Strong Buy rating(s)
Buy
18 Buy rating(s)
18 Buy rating(s)
19 Buy rating(s)
16 Buy rating(s)
Hold
3 Hold rating(s)
3 Hold rating(s)
2 Hold rating(s)
3 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$560.76$558.24$510.52$422.52
Predicted Upside10.60% Upside12.95% Upside14.24% Upside14.50% Upside
Get UnitedHealth Group Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for UNH and its competitors with MarketBeat's FREE daily newsletter.


UNH Stock Analyst Ratings By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

UNH Stock Price Target by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

UnitedHealth Group Stock vs. The Competition

TypeUnitedHealth GroupMedical CompaniesS&P 500
Consensus Rating Score
2.91
2.71
2.51
Consensus RatingModerate BuyBuyBuy
Predicted Upside9.18% Upside451.16% Upside33.72% Upside
News Sentiment RatingNeutral News
Positive News
Neutral News
MarketBeat
Community Rating
Outperform Votes
1602
81.20%
Underperform Votes
371
18.80%
Avg. Outperform Votes
170
66.93%
Avg. Underperform Votes
84
33.07%
Avg. Outperform Votes
840
69.14%
Avg. Underperform Votes
375
30.86%

Historical UnitedHealth Group Price Targets and Ratings

DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
6/16/2022Loop Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageBuy$575.00+26.06%
5/26/2022Sanford C. Bernstein
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeOutperform ➝ Market Perform$561.00+11.70%
5/25/2022Wells Fargo
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetOverweight$613.00 ➝ $612.00+22.31%
4/19/2022SVB Leerink
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOutperform$550.00 ➝ $600.00+12.34%
4/19/2022Raymond James
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetStrong-Buy$540.00 ➝ $620.00+16.09%
4/19/2022BMO Capital Markets
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetMarket Perform$510.00 ➝ $600.00+12.34%
4/18/2022Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost Target$512.00 ➝ $596.00+11.22%
4/18/2022Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOverweight$570.00 ➝ $577.00+8.19%
4/18/2022Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Ben Hendrix
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set TargetOutperform$563.00+5.27%
4/18/2022Deutsche Bank Aktiengesellschaft
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy$482.00 ➝ $549.00+2.65%
4/18/2022Credit Suisse Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOutperform$564.00 ➝ $595.00+11.25%
4/18/2022Oppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOutperform$550.00 ➝ $600.00+12.19%
4/7/2022Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost Target$575.00 ➝ $610.00+14.72%
3/30/2022Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOverweight$495.00 ➝ $565.00+10.63%
1/10/2022Edward Jones
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageBuy
12/20/2021Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy$500.00 ➝ $550.00+12.91%
12/14/2021The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageBuy$535.00+11.89%
12/1/2021UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Kavin Caliendo
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost TargetNeutral$435.00 ➝ $452.00+1.75%
10/15/2021Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Michael Newshel
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost TargetOutperform$360.00 ➝ $480.00+12.69%
7/16/2021Stephens
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Scott Fidel
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost TargetOverweight ➝ Overweight$440.00 ➝ $460.00+9.47%
7/16/2021Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy$450.00 ➝ $480.00+14.27%
7/9/2021Seaport Res Ptn
Subscribe to MarketBeat All Access for the recommendation accuracy rating
J. France
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy
6/1/2021Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy$450.00 ➝ $522.00+26.72%
4/21/2021Argus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeHold ➝ Buy$450.00+13.48%
12/2/2020JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost Target$360.00 ➝ $430.00+24.28%
12/2/2020Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOverweight$360.00 ➝ $375.00+9.91%
11/11/2020Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOverweight$385.00 ➝ $409.00+15.64%
10/15/2020Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetHold$310.00 ➝ $335.00+4.09%
5/21/2020SunTrust Banks
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy$340.00 ➝ $360.00+25.00%
12/4/2019Piper Jaffray Companies
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOverweight$312.00 ➝ $325.00+17.37%
7/15/2019Cleveland Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Steve Willoughby
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy
(Data available from 7/1/2017 forward. View 10+ years of historical ratings with our analyst ratings screener.)












UnitedHealth Group Price Target - Frequently Asked Questions

What is UnitedHealth Group's consensus rating and price target?

According to the issued ratings of 22 analysts in the last year, the consensus rating for UnitedHealth Group stock is Moderate Buy based on the current 3 hold ratings, 18 buy ratings and 1 strong buy rating for UNH. The average twelve-month price prediction for UnitedHealth Group is $560.76 with a high price target of $620.00 and a low price target of $452.00. Learn more on UNH's analyst rating history.

Do Wall Street analysts like UnitedHealth Group more than its competitors?

Analysts like UnitedHealth Group stock more than the stock of other Medical companies. The consensus rating for UnitedHealth Group is Moderate Buy while the average consensus rating for medical companies is Buy. Learn more on how UNH compares to other companies.

Do MarketBeat users like UnitedHealth Group more than its competitors?

MarketBeat users like UnitedHealth Group stock more than the stock of other Medical companies. 81.20% of MarketBeat users gave UnitedHealth Group an outperform vote while medical companies recieve an average of 66.93% outperform votes by MarketBeat users.

Is UnitedHealth Group being downgraded by Wall Street analysts?

Over the previous 90 days, UnitedHealth Group's stock had 1 downgrade by analysts.

Does UnitedHealth Group's stock price have much upside?

According to analysts, UnitedHealth Group's stock has a predicted upside of 12.97% based on their 12-month price targets.

This page (NYSE:UNH) was last updated on 7/1/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer.